Overview

Percutaneous Ethanol Injection for Primary Papillary Thyroid Microcarcinoma

Status:
Terminated
Trial end date:
2017-06-29
Target enrollment:
Participant gender:
Summary
We assess the effectiveness of percutaneous ethanol ablation for the treatment of thyroid cancer.
Phase:
N/A
Details
Lead Sponsor:
Yale University
Treatments:
Ethanol